155 related articles for article (PubMed ID: 30904896)
41. Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy.
Cianfrocca M; Lee S; Von Roenn J; Tulpule A; Dezube BJ; Aboulafia DM; Ambinder RF; Lee JY; Krown SE; Sparano JA
Cancer; 2010 Aug; 116(16):3969-77. PubMed ID: 20564162
[TBL] [Abstract][Full Text] [Related]
42. Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy.
Mukhtar F; Ilozumba M; Utuama O; Cimenler O
JAMA Oncol; 2018 Jan; 4(1):48-53. PubMed ID: 28837714
[TBL] [Abstract][Full Text] [Related]
43. Chylothorax in a patient with HIV-related Kaposi's sarcoma.
Cherian S; Umerah OM; Tufail M; Panchal RK
BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30674495
[TBL] [Abstract][Full Text] [Related]
44. Serosanguineous pleural effusions in AIDS-associated Kaposi's sarcoma.
O'Brien RF; Cohn DL
Chest; 1989 Sep; 96(3):460-6. PubMed ID: 2766805
[TBL] [Abstract][Full Text] [Related]
45. Pegylated liposomal doxorubicin as first line treatment in aids-related Kaposi's sarcoma: a real-life study.
Dalu D; Fasola C; Ammoni L; De Francesco D; Cona MS; Rota S; Ferrario S; Gambaro A; Tosca N; Piva S; La Verde N
J Chemother; 2021 Sep; 33(5):342-347. PubMed ID: 34060438
[TBL] [Abstract][Full Text] [Related]
46. Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi's sarcoma.
Martin-Carbonero L; Barrios A; Saballs P; Sirera G; Santos J; Palacios R; Valencia ME; Alegre M; Podzamczer D; González-Lahoz J;
AIDS; 2004 Aug; 18(12):1737-40. PubMed ID: 15280789
[TBL] [Abstract][Full Text] [Related]
47. Use of boosted protease inhibitors reduces Kaposi sarcoma incidence among male veterans with HIV infection.
Kowalkowski MA; Kramer JR; Richardson PR; Suteria I; Chiao EY
Clin Infect Dis; 2015 May; 60(9):1405-14. PubMed ID: 25586682
[TBL] [Abstract][Full Text] [Related]
48. Steroids are a risk factor for Kaposi's sarcoma-immune reconstitution inflammatory syndrome and mortality in HIV infection.
Fernández-Sánchez M; Iglesias MC; Ablanedo-Terrazas Y; Ormsby CE; Alvarado-de la Barrera C; Reyes-Terán G
AIDS; 2016 Mar; 30(6):909-14. PubMed ID: 26636923
[TBL] [Abstract][Full Text] [Related]
49. [Successful Treatment of Immune Reconstitution Inflammatory Syndrome with Corticosteroid for Patient with Kaposi's Sarcoma Extending into the Respiratory Tract and Both Lungs].
Shikawa T; Yanagisawa K; Ogawa Y; Uchiumi H; Gohda F; Handa H
Kansenshogaku Zasshi; 2017 Jan; 91(1):25-30. PubMed ID: 30277684
[TBL] [Abstract][Full Text] [Related]
50. Kaposi sarcoma in Southern Finland (2006-2018).
Kluger N; Blomqvist C; Kivelä P
Int J Dermatol; 2019 Nov; 58(11):1258-1263. PubMed ID: 31222805
[TBL] [Abstract][Full Text] [Related]
51. A Rare Gastrointestinal Presentation in an HIV-Infected Patient.
Abdelfatah MM; Tuttle B
Gastroenterology; 2017 May; 152(6):e7-e9. PubMed ID: 28388419
[No Abstract] [Full Text] [Related]
52. Fatal pulmonary Kaposi sarcoma in an HIV seronegative AIDS patient.
Zhang H; Wang HL; Zhong DR; Liu Y; Li NN; Zhang W; Xiao Y; Li TS
Clin Respir J; 2017 Nov; 11(6):1040-1044. PubMed ID: 26861193
[TBL] [Abstract][Full Text] [Related]
53. Kaposi's sarcoma in pregnancy after initiation of highly active antiretroviral therapy: a manifestation of immune reconstitution syndrome.
Adeyemo A; Wood C; Govind A
Int J STD AIDS; 2012 Dec; 23(12):905-6. PubMed ID: 23258835
[TBL] [Abstract][Full Text] [Related]
54. Timing of highly active antiretroviral therapy and chemotherapy for Kaposi's sarcoma in patients with HIV infection.
Loke WC; Spittle MF; Mitchell S; Kulasegaram R
Int J STD AIDS; 2006 Aug; 17(8):565-6. PubMed ID: 16925908
[TBL] [Abstract][Full Text] [Related]
55. Immune Reconstitution Inflammatory Syndrome Presenting as Disseminated Kaposi Sarcoma.
Ruzgas G; Eshan SH; Ramanathan S; Gotimukul A; Bodapati RK
Cureus; 2023 Feb; 15(2):e34832. PubMed ID: 36919058
[TBL] [Abstract][Full Text] [Related]
56. AIDS-related gastrointestinal kaposi sarcoma in Korea: a case report and review of the literature.
Chung CY; Park SW; Myung E; Cho DK; Song YA; Park KJ; Jang HC; Joo YE
Korean J Gastroenterol; 2012 Sep; 60(3):166-71. PubMed ID: 23018538
[TBL] [Abstract][Full Text] [Related]
57. Cutaneous HIV-associated Kaposi sarcoma: a potential setting for management by clinical observation.
Beatrous SV; Grisoli SB; Riahi RR; Cohen PR
Dermatol Online J; 2017 Jun; 23(6):. PubMed ID: 28633734
[TBL] [Abstract][Full Text] [Related]
58. Pulmonary Kaposi Sarcoma with Osseous Metastases in an Human Immunodeficiency Virus (HIV) Patient: A Remarkable Response to Highly Active Antiretroviral Therapy.
Dirweesh A; Khan MY; Hamiz SF; Karabulut N
Am J Case Rep; 2017 Feb; 18():181-185. PubMed ID: 28216610
[TBL] [Abstract][Full Text] [Related]
59. S1 Guidelines for the Kaposi Sarcoma.
Esser S; Schöfer H; Hoffmann C; Claßen J; Kreuter A; Leiter U; Oette M; Becker JC; Ziemer M; Mosthaf F; Sirokay J; Ugurel S; Potthoff A; Helbig D; Bierhoff E; Schulz TF; Brockmeyer NH; Grabbe S
J Dtsch Dermatol Ges; 2022 Jun; 20(6):892-904. PubMed ID: 35657085
[TBL] [Abstract][Full Text] [Related]
60. Oral Kaposi sarcoma: a case of immune reconstitution inflammatory syndrome.
Papagatsia Z; Jones J; Morgan P; Tappuni AR
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jul; 108(1):70-5. PubMed ID: 19464210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
